Symbotic Inc. acquires OhmniLabs to enhance robotics solutions in healthcare and supply chain automation.
Quiver AI Summary
Symbotic Inc. announced the completion of its acquisition of OhmniLabs, a robotics innovator specializing in healthcare solutions, on December 12, 2024. This strategic move aims to combine Symbotic's expertise in large-scale automation with OhmniLabs' advanced mobile robots and AI technologies, enhancing automation capabilities in both supply chain and healthcare sectors. Symbotic's CEO, Rick Cohen, emphasized the potential for innovation stemming from the acquisition, while OhmniLabs Co-founder Jared Go expressed excitement about collaborating with a leader in robotics innovation to further their mission of developing impactful robotics solutions. Founded in 2015, OhmniLabs is recognized for its autonomous disinfection and telepresence robots designed to improve health environments globally.
Potential Positives
- Symbotic has completed the strategic acquisition of OhmniLabs, enhancing its capabilities in A.I.-enabled robotics and expanding into the healthcare market.
- The acquisition brings in talent and expertise from OhmniLabs, allowing Symbotic to innovate and develop advanced automation solutions across various sectors.
- This move positions Symbotic to deliver significant advancements in both supply chain automation and healthcare robotics, potentially increasing its market share and customer base in these industries.
- OhmniLabs is recognized for its successful autonomous disinfection and telepresence robots, which could complement Symbotic's existing offerings and strengthen its reputation as a leader in robotics innovation.
Potential Negatives
- The acquisition may divert resources and focus away from Symbotic's core supply chain operations, creating potential integration challenges with OhmniLabs' technology and workforce.
- The reliance on forward-looking statements acknowledges the possibility of risks and uncertainties, suggesting that the anticipated benefits of the acquisition are not guaranteed.
- Details on how Symbotic plans to achieve synergies from the acquisition are lacking, which could raise concerns among investors about the realization of the expected advantages.
FAQ
What company did Symbotic acquire?
Symbotic acquired OhmniLabs, a Silicon Valley-based robotics solutions innovator for health care.
What is the focus of OhmniLabs' robotics solutions?
OhmniLabs specializes in autonomous disinfection and telepresence robots for creating safe and healthy environments.
How will the acquisition benefit Symbotic?
The acquisition will enhance Symbotic's automation capabilities and drive innovation in both health care and supply chain sectors.
What is Symbotic's role in the supply chain?
Symbotic is a leader in A.I.-powered robotics, transforming warehouses into strategic assets for major retailers and distributors.
When was OhmniLabs founded?
OhmniLabs was founded in 2015 by experts in robotics and has focused on rapid innovation in the field.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SYM Insider Trading Activity
$SYM insiders have traded $SYM stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $SYM stock by insiders over the last 6 months:
- MICHAEL DAVID DUNN (See Remarks) has traded it 8 times. They made 0 purchases and 8 sales, selling 79,931 shares.
- CAROL J. HIBBARD (Chief Financial Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 22,821 shares.
- TODD KRASNOW has traded it 6 times. They made 0 purchases and 6 sales, selling 25,000 shares.
- WILLIAM M III BOYD (Chief Strategy Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 17,652 shares.
- MERLINE SAINTIL sold 5,250 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SYM Hedge Fund Activity
We have seen 119 institutional investors add shares of $SYM stock to their portfolio, and 146 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAILLIE GIFFORD & CO added 3,410,050 shares (+32.0%) to their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 937,229 shares (-90.0%) from their portfolio in Q3 2024
- FRONTIER CAPITAL MANAGEMENT CO LLC added 731,076 shares (+160.1%) to their portfolio in Q3 2024
- CANADA PENSION PLAN INVESTMENT BOARD removed 695,100 shares (-89.6%) from their portfolio in Q3 2024
- GOLDMAN SACHS GROUP INC added 643,921 shares (+1590.2%) to their portfolio in Q3 2024
- BANK OF AMERICA CORP /DE/ added 511,250 shares (+2462.1%) to their portfolio in Q3 2024
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 510,581 shares (+1069.8%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
WILMINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM ), a leader in A.I.-enabled robotics technology for the supply chain, today announced that it has completed the acquisition of OhmniLabs, a Silicon Valley-based innovator in the field of robotics solutions for health care.
“Combining Symbotic’s expertise in large-scale automation with OhmniLabs’ ground-breaking mobile robots, vision and A.I. solutions will enable the development of unparalleled automation innovations across different settings,” said Rick Cohen, Executive Chairman and CEO of Symbotic. “We were drawn to OhmniLabs for its impressive talent and industry experience that will enable our expansion beyond the four walls of the warehouse.”
Founded in 2015 by robotics experts, OhmniLabs has pioneered a fully in-house development and manufacturing model, enabling rapid innovation and speed-to-market for cutting-edge robotics solutions. The company is best known for its autonomous disinfection and telepresence robots, which create safer and healthier environments globally. With the strategic acquisition of OhmniLabs’ industry expertise and talented robotics team, Symbotic will be better positioned to both expand its leading automation capabilities for supply chain customers while delivering enhanced innovation to customers in the health care industry.
“OhmniLabs’ mission has been to develop meaningful robotics to provide real-world solutions, and we have made significant progress with the support of our loyal team members and customers. Being a part of Symbotic, a true leader in robotics innovation, will propel this vision forward to deliver cutting-edge solutions that redefine what’s possible in health care, logistics and beyond,” said Jared Go, Co-founder and CTO, OhmniLabs.
ABOUT SYMBOTIC
Symbotic is an automation technology leader reimagining the supply chain with its end-to-end, A.I.-powered robotic and software platform. Symbotic reinvents the warehouse as a strategic asset for the world’s largest retail, wholesale, and food & beverage companies. Applying next-generation technology, high-density storage and machine learning to solve today's complex distribution challenges, Symbotic enables companies to move goods with unmatched speed, agility, accuracy and efficiency. As the backbone of commerce, Symbotic transforms the flow of goods and the economics of the supply chain for its customers. For more information, visit www.symbotic.com .
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, statements about Symbotic’s acquisition of substantially all of the assets of OhmniLabs and Symbotic’s expectations or predictions of future financial or business performance or conditions. Such forward-looking statements involve risks and uncertainties that may cause actual events, results or performance to differ materially from those indicated by such statements. Certain of these risks are identified and discussed in Symbotic’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 4, 2024. These forward-looking statements are expressed in good faith, and Symbotic believes there is a reasonable basis for them. However, there can be no assurance that the events, results or trends identified in these forward-looking statements will occur or be achieved. Forward-looking statements speak only as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. Symbotic is not under any obligation, and expressly disclaims any obligation to update, alter or otherwise revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Readers should carefully review the statements set forth in the reports that Symbotic has filed or will file from time to time with the SEC.
INVESTOR RELATIONS CONTACT
Charlie Anderson
Vice President, Investor Relations & Corporate Development
ir@symbotic.com
MEDIA INQUIRIES